Michael Fiegl
Department of Internal Medicine
Division of Hematology and Oncology
Innsbruck University Hospital
Anichstrasse 35
Austria
Name/email consistency: high
- Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria. Fiegl, M., Falkner, A., Hopfinger, G., Brugger, S., Zabernigg, A., Bauer, F., Haslbauer, F., Demirtas, D., Grossschmidt, P., Tatzreiter, G., Gastl, G., Greil, R. Cancer (2006)
- The utility of fluorescence in-situ hybridization in the diagnosis of malignant pleural effusion. Fiegl, M. Curr. Opin. Pulm. Med (2005)
- Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions. Fiegl, M., Haun, M., Massoner, A., Krugmann, J., Müller-Holzner, E., Hack, R., Hilbe, W., Marth, C., Duba, H.C., Gastl, G., Grünewald, K. J. Clin. Oncol. (2004)
- Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH). Fiegl, M., Massoner, A., Haun, M., Sturm, W., Kaufmann, H., Hack, R., Krugmann, J., Fritzer-Szekeres, M., Grünewald, K., Gastl, G. Br. J. Cancer (2004)
- Diffuse large B-cell lymphoma with infiltration-associated peripheral neuropathy and paraneoplastic myopathy with a prolonged course over seven years. Fiegl, M., Muigg, A., Smekal, A., Krugmannd, J., Dirnhofer, S., Greil, R. Leuk. Lymphoma (2002)









